With over 1000 attendees set to attend Barcelona 2014 is the world’s largest and most influential focused forum to unite commercial pharma executives. Conference Director, Lucy Fisher stated, ’2014 is set to be a record breaking event. We already have more pharma delegates, speakers and exhibitors than ever before’. She continued, ‘However, due to this overwhelming response, only a limited number of conference passes now remain’.
Industry leaders reveal the future of customer centric pharma
100+ leading companies including, Pfizer, Eli Lilly, Novartis, Janssen, UCB, Teva, Shire, Sanofi, Baxter, Merck, Celgene, Roche, AstraZeneca, GSK and many more will identify the business practices and innovative strategies to deliver real value to your customer. Andrew Schorr, Founder and Host at Patient Power commented “The empowered patient is pharma’s best friend. eyeforpharma Barcelona will bring together innovative discussions to support and increase patient education amongst leading pharma brands. Patients are connecting globally and it is time for pharma to keep ahead of the curve”.
Other key issues addressed at eyeforpharma Barcelona will include:
Build value with your customer in an era of climate change: Understand how you can deliver true value to physicians, patients, payers and non-traditional stakeholders.
- Evolve to meet the needs of today’s customer: how to put in place the right training, systems and tools to stand out, incorporate KAM and ultimately build fruitful long-term customer relationships.
- Achieve true multichannel: with better-leveraged digital, synchronised channel selection and cross-company implementation – whilst maintaining innovation with your core team.
Register your place before tickets run-out
Register via the secure link to book your place amongst 1,000+ pharmaceutical industry decision makers at Barcelona 2014.
eyeforpharma is a hub for senior-level pharma executives, patient advocacy groups and other health experts to exchange ideas and stay up to date with shifting trends and practices within the pharmaceutical industry. We provide industry-focused commentary, events, reports, and other valuable expert-driven content. Our ultimate aim is to facilitate positive change through discussion and debate, enabling dialogue within the industry and driving the positive benefits that pharmaceuticals can offer.
For more information contact: